Zevra Therapeutics Inc. (NASDAQ: ZVRA)
$7.0400
+0.2600 ( +3.84% ) 592.1K
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Market Data
Open
$7.0400
Previous close
$6.7800
Volume
592.1K
Market cap
$359.63M
Day range
$6.6800 - $7.3140
52 week range
$3.8900 - $8.4399
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 79 | Aug 14, 2024 |
8-k | 8K-related | 16 | Aug 13, 2024 |
8-k | 8K-related | 17 | Aug 09, 2024 |
8-k | 8K-related | 13 | Aug 08, 2024 |
8-k | 8K-related | 16 | Aug 05, 2024 |
4 | Insider transactions | 1 | Jul 17, 2024 |
4 | Insider transactions | 1 | Jul 16, 2024 |
4 | Insider transactions | 1 | Jul 15, 2024 |
8-k | 8K-related | 17 | Jul 12, 2024 |
8-k | 8K-related | 16 | Jul 09, 2024 |